FDA Approves Novel Non-Opioid Painkiller Journavx
The FDA approved Vertex's non-opioid painkiller, Journavx, for moderate-to-severe acute pain, offering an addiction-free alternative impacting 80 million annual U.S. patients and potentially generating over $1 billion in annual sales.
FDA Approves Novel Non-Opioid Painkiller Journavx
The FDA approved Vertex's non-opioid painkiller, Journavx, for moderate-to-severe acute pain, offering an addiction-free alternative impacting 80 million annual U.S. patients and potentially generating over $1 billion in annual sales.
Progress
44% Bias Score
Medical Misogyny Delays Diagnosis of Heterotopic Pregnancy
Keira Rumble's experience of medical misogyny led to a delayed diagnosis of a heterotopic pregnancy, highlighting the insufficient research on women's health and inadequate training of medical professionals in Australia.
Medical Misogyny Delays Diagnosis of Heterotopic Pregnancy
Keira Rumble's experience of medical misogyny led to a delayed diagnosis of a heterotopic pregnancy, highlighting the insufficient research on women's health and inadequate training of medical professionals in Australia.
Progress
32% Bias Score
Daughter's Grief Spurs Assisted Dying Advocacy
A daughter's grief over her father's painful death from cancer fuels her campaign for assisted dying legislation in England and Wales.
Daughter's Grief Spurs Assisted Dying Advocacy
A daughter's grief over her father's painful death from cancer fuels her campaign for assisted dying legislation in England and Wales.
Progress
0% Bias Score
New Osteoarthritis Treatment Guidelines
New recommendations for non-drug osteoarthritis treatment highlight the importance of adapted physical activity, weight loss, and avoiding ineffective therapies like cryo/thermo-therapy.
New Osteoarthritis Treatment Guidelines
New recommendations for non-drug osteoarthritis treatment highlight the importance of adapted physical activity, weight loss, and avoiding ineffective therapies like cryo/thermo-therapy.
Progress
0% Bias Score
FDA Approves First New Non-Opioid Painkiller in Over Two Decades
The FDA approved suzetrigina, a new non-opioid painkiller, offering an alternative to opioids for acute pain; studies show comparable effectiveness to Vicodin for post-surgical pain, but further research is needed for chronic pain.
FDA Approves First New Non-Opioid Painkiller in Over Two Decades
The FDA approved suzetrigina, a new non-opioid painkiller, offering an alternative to opioids for acute pain; studies show comparable effectiveness to Vicodin for post-surgical pain, but further research is needed for chronic pain.
Progress
48% Bias Score
Man Survives Near-Death Experiences, Battles "Suicide Disease"
A 47-year-old man, Josh, recounts surviving multiple near-death experiences and his 12-year battle with trigeminal neuralgia (TGN), a debilitating condition causing extreme facial pain that led to three comas; he is currently in remission.
Man Survives Near-Death Experiences, Battles "Suicide Disease"
A 47-year-old man, Josh, recounts surviving multiple near-death experiences and his 12-year battle with trigeminal neuralgia (TGN), a debilitating condition causing extreme facial pain that led to three comas; he is currently in remission.
Progress
36% Bias Score
The Power and Limits of Placebos
This article explores the mechanisms behind the placebo effect, including treatment expectation and learned conditioning, and discusses its limitations.
The Power and Limits of Placebos
This article explores the mechanisms behind the placebo effect, including treatment expectation and learned conditioning, and discusses its limitations.
Progress
0% Bias Score